30,813 Shares in Celanese Corporation $CE Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company purchased a new stake in Celanese Corporation (NYSE:CE) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 30,813 shares of the basic materials company’s stock, valued at approximately $1,417,000.

A number of other large investors have also recently bought and sold shares of CE. Geneos Wealth Management Inc. boosted its position in Celanese by 111.1% in the second quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company’s stock valued at $28,000 after buying an additional 270 shares in the last quarter. National Bank of Canada FI acquired a new stake in shares of Celanese during the third quarter worth approximately $34,000. Smartleaf Asset Management LLC raised its stake in shares of Celanese by 100.0% in the second quarter. Smartleaf Asset Management LLC now owns 662 shares of the basic materials company’s stock valued at $38,000 after acquiring an additional 331 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Celanese by 175.7% in the 4th quarter. UMB Bank n.a. now owns 896 shares of the basic materials company’s stock worth $38,000 after acquiring an additional 571 shares in the last quarter. Finally, Kestra Advisory Services LLC acquired a new position in shares of Celanese in the 4th quarter worth approximately $41,000. 98.87% of the stock is currently owned by institutional investors.

Insider Activity at Celanese

In other Celanese news, SVP Mark Murray purchased 2,153 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were bought at an average price of $45.52 per share, with a total value of $98,004.56. Following the completion of the transaction, the senior vice president directly owned 30,432 shares in the company, valued at $1,385,264.64. This trade represents a 7.61% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.34% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on CE shares. Citigroup decreased their target price on Celanese from $80.00 to $68.00 and set a “buy” rating on the stock in a report on Wednesday, June 24th. Bank of America cut their price target on Celanese from $72.00 to $63.00 and set a “buy” rating for the company in a report on Tuesday, June 30th. BMO Capital Markets reduced their price target on shares of Celanese from $57.00 to $54.00 and set a “market perform” rating on the stock in a research report on Wednesday, August 5th. Wells Fargo & Company lowered their price target on shares of Celanese from $80.00 to $65.00 and set an “overweight” rating for the company in a report on Thursday, August 6th. Finally, Morgan Stanley reduced their price objective on Celanese from $72.00 to $58.00 and set an “equal weight” rating on the stock in a report on Thursday, July 16th. Nine equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $63.71.

Celanese Stock Down 3.0%

NYSE:CE opened at $45.25 on Friday. Celanese Corporation has a 12-month low of $35.13 and a 12-month high of $70.70. The company has a quick ratio of 0.87, a current ratio of 1.45 and a debt-to-equity ratio of 2.33. The firm has a market capitalization of $4.97 billion, a P/E ratio of -4.23, a P/E/G ratio of 0.30 and a beta of 0.76. The stock’s fifty day simple moving average is $45.73 and its 200-day simple moving average is $53.18.

Celanese (NYSE:CE) last posted its earnings results on Tuesday, August 4th. The basic materials company reported $2.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.23 by $0.22. The company had revenue of $2.75 billion during the quarter, compared to analyst estimates of $2.75 billion. Celanese had a positive return on equity of 13.04% and a negative net margin of 12.04%.The company’s revenue for the quarter was up 8.7% compared to the same quarter last year. During the same period in the previous year, the company earned $1.44 EPS. Celanese has set its Q3 2026 guidance at 1.350-1.750 EPS. Equities research analysts expect that Celanese Corporation will post 5.99 earnings per share for the current year.

Celanese Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, August 10th. Investors of record on Tuesday, July 28th were paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, July 28th. Celanese’s dividend payout ratio (DPR) is presently -1.12%.

Celanese Profile

Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.

In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.